Interested in learning how Immunophotonics, Inc. continues to explore the ability of IP-001 to transform a routine interventional-oncology procedure into a systemic immunotherapy against cancer. Tomas Hode, PhD, Co-Founder, CIO, and President at Immunophotonics, Inc. will be attending the European Conference on Interventional Oncology (EICO 2022) in Vienna, Austria April 24 – 27, 2022. This year the focus will be on immuno-oncology where we are and where it is headed. Tomas is looking forward to meeting with renowned experts sharing their tips and experience on a number of procedures including lung and liver ablations.